Basic Information
| RNALocate ID: | RLID:11004308 |
| RNA Symbol: | hsa-miR-1299 |
| Localization: | Extracellular Vesicle |
RNA Information
| RNA Name: | hsa-miR-1299 |
| RNA ID: | miRBase:MIMAT0005887 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 28588009 |
| Tissue/Cell Line: | Plasma |
| Method: | NanoString nCounter assay |
| Condition: | Liposarcoma|Healthy |
|
Heat map representation of the top deregulated miRNAs in LPS-PBVs. Originally published in Cancer Res. Casadei L, et al, 2017. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
| Description: | To determine which miRNAs were secreted from LPS cells and elucidate their possible role as prognostic “signatures,” we performed a NanoString profiling on RNA samples isolated from peripheral blood plasma Vesicles (PBVs) derived from 16 human LPS patient samples and from 8 healthy controls Supplementary Table S1. Figure 1A depicts a heatmap of the most differentially expressed PBVs miRNAs (102 miRNAs). Data are collected from Figure 1A. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11004309 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000771 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001686 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-1299 | High-grade serous ovarian carcinoma | MNDR-E-MI-10146 |
| MNDR | hsa-miR-1299 | Ovarian clear cell carcinoma | MNDR-E-MI-10147 |
| MNDR | hsa-miR-1299 | Estrogen-receptor positive breast cancer | MNDR-E-MI-10148 |
| MNDR | hsa-miR-1299 | Estrogen-receptor negative breast cancer | MNDR-E-MI-10149 |
| MNDR | hsa-miR-1299 | Progesterone-receptor positive breast cancer | MNDR-E-MI-10150 |
| MNDR | hsa-miR-1299 | Progesterone-receptor negative breast cancer | MNDR-E-MI-10151 |
| MNDR | hsa-miR-1299 | Her2-receptor positive breast cancer | MNDR-E-MI-10152 |
| MNDR | hsa-miR-1299 | Alzheimer disease | MNDR-E-MI-10153 |
| MNDR | hsa-miR-1299 | Intracranial aneurysm | MNDR-E-MI-10154 |
| MNDR | hsa-miR-1299 | Lung cancer | MNDR-E-MI-10155 |
| MNDR | hsa-miR-1299 | Parkinson disease | MNDR-E-MI-10156 |
| MNDR | hsa-miR-1299 | Breast cancer | MNDR-E-MI-10157 |
| MNDR | hsa-miR-1299 | Nephroblastoma | MNDR-E-MI-10158 |
| MNDR | hsa-miR-1299 | Relapsing-remitting multiple sclerosis | MNDR-E-MI-10159 |
| MNDR | hsa-miR-1299 | Familial ovarian cancer | MNDR-E-MI-10160 |
| MNDR | hsa-mir-1299 | Ovarian neoplasms | MNDR-E-MI-10161 |
| MNDR | hsa-miR-1299 | Invasive ductal carcinoma | MNDR-E-MI-10162 |
| MNDR | hsa-miR-1299 | Glioblastoma | MNDR-E-MI-10163 |
| MNDR | hsa-miR-1299 | Liposarcoma | MNDR-E-MI-10164 |
| MNDR | hsa-miR-1299 | Ovarian carcinoma | MNDR-E-MI-10165 |
| MNDR | hsa-miR-1299 | Pancreatic adenocarcinoma | MNDR-E-MI-10166 |
| MNDR | hsa-miR-1299 | Cholangiocarcinoma | MNDR-E-MI-10167 |
| MNDR | hsa-miR-1299 | Hepatocellular carcinoma | MNDR-E-MI-10168 |
| MNDR | hsa-mir-1299 | Hepatocellular carcinoma | MNDR-E-MI-10169 |
| MNDR | hsa-miR-1299 | Familiar ovarian carcinoma | MNDR-E-MI-10170 |
| MNDR | hsa-miR-1299 | Retinoblastoma | MNDR-E-MI-10171 |
| MNDR | hsa-miR-1299 | Hodgkin lymphoma | MNDR-E-MI-10172 |
| MNDR | hsa-miR-1299 | Colorectal cancer | MNDR-E-MI-10173 |
| MNDR | hsa-miR-1299 | Nasopharynx carcinoma | MNDR-E-MI-10174 |
| MNDR | hsa-miR-1299 | Nasopharyngeal cancer | MNDR-E-MI-10175 |
| MNDR | hsa-miR-1299 | Stroke lacunar | MNDR-E-MI-10176 |
| MNDR | hsa-miR-1299 | Breast cancer her3+ negative | MNDR-E-MI-10177 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CDR1-AS | Homo sapiens | RR00312775 |
TOP